Macular Degeneration Implant Approval Requires Two Post-Market Studies

VisionCare Ophthalmic Technologies must conduct two post-market studies of its IMT implantable miniature telescope as a condition of its July 1 PMA approval for end-stage age-related macular degeneration (AMD)